[PDF][PDF] Efficacy and safety of Molnupiravir in COVID‑19 patients: a systematic
Background Molnupiravir is an oral antiviral drug that received Emergency Use
Authorization in three countries for the treatment of mild COVID-19. The aim of this …
Authorization in three countries for the treatment of mild COVID-19. The aim of this …
[HTML][HTML] Efficacy and safety of Molnupiravir in COVID-19 patients: A systematic review
Background Molnupiravir is an oral antiviral drug that received Emergency Use
Authorization in three countries for the treatment of mild COVID-19. The aim of this …
Authorization in three countries for the treatment of mild COVID-19. The aim of this …
Efficacy and safety of molnupiravir treatment for COVID-19: a systematic review and meta-analysis of randomized controlled trials
F Tian, Q Feng, Z Chen - International Journal of Antimicrobial Agents, 2023 - Elsevier
Introduction At present, there are some differences in the research results of molnupiravir.
The purpose of this study was to evaluate the efficacy and safety of molnupiravir in the …
The purpose of this study was to evaluate the efficacy and safety of molnupiravir in the …
Molnupiravir: an antiviral drug against COVID-19
Abstract SARS-CoV-2, the virus responsible for COVID-19, has caused numerous deaths
worldwide and poses significant challenges. Researchers have recently studied a new …
worldwide and poses significant challenges. Researchers have recently studied a new …
Molnupiravir for Treatment of Adults with Mild or Moderate COVID-19: A Systematic Review and Meta-Analysis
Y Gao, M Liu, Z Li, J Xu, J Zhang… - Available at SSRN …, 2023 - papers.ssrn.com
Background: The effects of molnupiravir in treating COVID-19 remain uncertain. This
systematic review aimed to evaluate the efficacy and safety of molnupiravir for adult patients …
systematic review aimed to evaluate the efficacy and safety of molnupiravir for adult patients …
Virology and Safety profile of Molnupiravir at three different doses: A systematic review and Meta-analysis
Molnupiravir (also known as EIDD-2801/MK-4482), which is used as an antiviral drug has its
mechanism of action by incorporating into the viral genome increasing errors, mismatching …
mechanism of action by incorporating into the viral genome increasing errors, mismatching …
Safety Profile of Molnupiravir with Significant Effect on COVID-19: A Review
T Mukherjee, P Mal, AK Upadhyay… - Current Drug …, 2023 - ingentaconnect.com
Background: As the COVID era unfolds, researchers reveal that rapid changes in viral
genetic material allow viruses to circumvent challenges triggered by the host immune …
genetic material allow viruses to circumvent challenges triggered by the host immune …
Optimal dose and safety of the novel oral anti-viral molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study
SH Khoo, R Fitzgerald, T Fletcher… - Journal of Antimicrobial …, 2021 - eprints.soton.ac.uk
Objectives: AGILE is a Phase Ib/IIa platform for rapidly evaluating COVID-19 treatments. In
this trial (NCT04746183) we evaluated the safety and optimal dose of molnupiravir in …
this trial (NCT04746183) we evaluated the safety and optimal dose of molnupiravir in …
Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis
Background The role of molnupiravir for coronavirus disease 2019 (COVID-19) treatment is
unclear. Methods We conducted a systematic review until 1 November 2022 searching for …
unclear. Methods We conducted a systematic review until 1 November 2022 searching for …
Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control …
The efficacy of molnupiravir in treating patients with coronavirus disease 2019 (COVID‐19)
has been inconsistent across randomized controlled trials (RCTs). Thus, this meta‐analysis …
has been inconsistent across randomized controlled trials (RCTs). Thus, this meta‐analysis …